Ngā hua rapu - Oluf Andersen

  • E whakaatu ana i te 1 - 14 hua o te 14
Whakamahine hua
  1. 1
    Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis

    Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis mā Oluf Andersen

    I whakaputaina 2004
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Clinical studies on multiple sclerosis

    Clinical studies on multiple sclerosis mā Tore Broman, Oluf Andersen, Lorenz Bergmann

    I whakaputaina 2009
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Treatment of myasthenia gravis with methylprednisolone pulse: a double blind study

    Treatment of myasthenia gravis with methylprednisolone pulse: a double blind study mā C. Lindberg, Oluf Andersen, Ann‐Kari Lefvert

    I whakaputaina 1998
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    The effect of phytic acid on the absorption of calcium and phosphorus: 3. In children.

    The effect of phytic acid on the absorption of calcium and phosphorus: 3. In children. mā E. Hoff‐Jørgensen, Oluf Andersen, G. Nielsen

    I whakaputaina 1946
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Treatment Options for Epstein-Barr Virus-Related Disorders of the Central Nervous System

    Treatment Options for Epstein-Barr Virus-Related Disorders of the Central Nervous System mā Oluf Andersen, Ingemar Ernberg, Anna Karin Hedström

    I whakaputaina 2023
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis

    Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis mā Jan Lycke, J.-E. Karlsson, Oluf Andersen, Lars Rosengren

    I whakaputaina 1998
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancy

    A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancy mā Bengt Skoog, Björn Runmarker, Stefan Winblad, Sven Ekholm, Oluf Andersen

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Quantitative Vascular Pathology and Phenotyping Familial and Sporadic Cerebral Small Vessel Diseases

    Quantitative Vascular Pathology and Phenotyping Familial and Sporadic Cerebral Small Vessel Diseases mā Lucinda Craggs, Christian Hagel, Gregor Kuhlenbäeumer, Anne Börjesson‐Hanson, Oluf Andersen, Matti Viitanen, Hannu Kalimo, Catriona McLean, Janet Y. Slade, Roslyn Hall, Arthur E. Oakley, Yumi Yamamoto, Vincent Deramecourt, Raj N. Kalaria

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs

    Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs mā Helen Tedeholm, Jan Lycke, Bengt Skoog, Vera Lisovskaja, Jan Hillert, Charlotte Dahle, Jan Fagius, S. Fredrikson, Anne‐Marie Landtblom, Clas Malmeström, C. Martin, Fredrik Piehl, B. Runmarker, Leszek Stawiarz, Magnus Vrethem, Olle Nerman, Oluf Andersen

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Epstein–Barr virus infection after adolescence and human herpesvirus 6A as risk factors for multiple sclerosis

    Epstein–Barr virus infection after adolescence and human herpesvirus 6A as risk factors for multiple sclerosis mā Martin Biström, Daniel Jons, Elin Engdahl, Rasmus Gustafsson, Jiaqi Huang, Nicole Brenner, Julia Butt, Lucía Alonso-Magdalena, Martin Gunnarsson, Magnus Vrethem, Noemi Bender, Tim Waterboer, Gabriel Granåsen, Tomas Olsson, Ingrid Kockum, Oluf Andersen, Anna Fogdell‐Hahn, Peter Sundström

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis

    Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis mā Jesse Huang, Katarina Tengvall, Izaura Bomfim Lima, Anna Karin Hedström, Julia Butt, Nicole Brenner, Alexandra Gyllenberg, Pernilla Stridh, Mohsen Khademi, Ingemar Ernberg, Faiez Al Nimer, Ali Manouchehrinia, Jan Hillert, Lars Alfredsson, Oluf Andersen, Peter Sundström, Tim Waterboer, Tomas Olsson, Ingrid Kockum

    I whakaputaina 2024
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis—a presymptomatic case–control study

    Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis—a presymptomatic case–control study mā Viktor Grut, Martin Biström, Jonatan Salzer, Pernilla Stridh, Daniel Jons, Rasmus Gustafsson, Anna Fogdell‐Hahn, Jesse Huang, Nicole Brenner, Julia Butt, Noemi Bender, Anna Lindam, Lucía Alonso-Magdalena, Martin Gunnarsson, Magnus Vrethem, Tomas Bergström, Oluf Andersen, Ingrid Kockum, Tim Waterboer, Tomas Olsson, Peter Sundström

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple Sclerosis

    Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple Sclerosis mā Elin Engdahl, Rasmus Gustafsson, Jesse Huang, Martin Biström, Izaura Lima Bomfim, Pernilla Stridh, Mohsen Khademi, Nicole Brenner, Julia Butt, Angelika Michel, Daniel Jons, Maria Hortlund, Lucía Alonso-Magdalena, Anna Karin Hedström, Louis Flamand, Masaru Ihira, Tetsushi Yoshikawa, Oluf Andersen, Jan Hillert, Lars Alfredsson, Tim Waterboer, Peter Sundström, Tomas Olsson, Ingrid Kockum, Anna Fogdell‐Hahn

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    MRI characteristics and scoring in HDLS due to <i>CSF1R</i> gene mutations

    MRI characteristics and scoring in HDLS due to <i>CSF1R</i> gene mutations mā Christina Sundal, Jay A. van Gerpen, Alexandra M. Nicholson, Christian Wider, Elizabeth A. Shuster, Jan Aasly, Salvatore Spina, Bernardino Ghetti, Sigrun Roeber, James Garbern, Anne Börjesson‐Hanson, Alex Tselis, Russell H. Swerdlow, Bradley B. Miller, Shinsuke Fujioka, Michael G. Heckman, Ryan J. Uitti, Keith A. Josephs, Matt Baker, Oluf Andersen, Rosa Rademakers, Dennis W. Dickson, Daniel F. Broderick, Zbigniew K. Wszołek

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: